Core Viewpoint - Recent trading activity indicates a reduction in holdings by southbound funds in Baize Medical (02609.HK), with a total net reduction of 63.54 million shares over the past 20 trading days, despite some periods of net increases [1][2]. Group 1: Trading Activity - On February 2, 2026, southbound funds reduced their holdings by 37,800 shares, representing a decrease of 0.05% [2]. - Over the last five trading days, there were three days of reductions, totaling a net decrease of 635,400 shares [1]. - In the last 20 trading days, there were 13 days of net increases, with a cumulative net increase of 8.346 million shares [1]. Group 2: Company Overview - Baize Medical Group primarily engages in investment and provision of medical services related to oncology, offering comprehensive services throughout the cancer care cycle, including screening, diagnosis, treatment, and rehabilitation [2]. - The company operates mainly in the Chinese market, providing hospital services, hospital management, and supplying pharmaceuticals, medical devices, and consumables [2]. - Services include cancer diagnosis, treatment, rehabilitation, end-of-life care, early cancer screening, cancer vaccination, and health management for potential healthy populations [2].
佰泽医疗（02609.HK）：2月2日南向资金减持3.78万股